| |
| |
 | |  | | | ¼Ö°í¹ÙÀÌ¿À¸ÞµðÄ® (043100) Solco Biomedical Co., Ltd. | ÄÚ½º´Ú - ÁßÇü | | | | ÷´Ü ÀÇ·á°øÇбâ±â Àü¹®¾÷ü | ÀÇ·á¿ë ±â±â | | |  | |  | |
| |
|  | [´ÜÀ§ : ¿ø,ÁÖ] | | ±¸ºÐ | 2008.12 | 2009.12 | 2010.12 | 2011.03 | | ¾×¸é°¡ | 500 | 500 | 500 | 500 | | ÃÖ°íÁÖ°¡ | 1,220 | 1,090 | 965 | 1,325 | | ÃÖÀúÁÖ°¡ | 355 | 470 | 560 | 759 | | º¸ÅëÁÖ¹ßÇàÁÖ½Ä | 45,041,040 | 46,154,212 | 46,154,212 | 48,566,084 | | ¿ì¼±ÁÖ¹ßÇàÁÖ¼ö | - | - | - | - | | ½Ã°¡ÃѾ×(¾ï¿ø) | 207 | 355 | 304 | 565 | | ¹è´ç·ü(%) | - | - | - | - | |
|  | [´ÜÀ§ : ¿ø] | | ±¸ºÐ | 2008.12 | 2009.12 | 2010.12 | 2011.03 | | ÁÖ´ç¼øÀÌÀÍ(EPS) | 14 | 27 | -53 | 4 | | ÁÖ´ç¸ÅÃâ¾×(SPS) | 673 | 729 | 635 | 571 | | ÁÖ´ç¼øÀÚ»ê(BPS) | 979 | 986 | 924 | 947 | | ÁÖ´çÇö±ÝÈ帧(CPS) | 101.9 | 98.7 | 16.0 | 22.4 | |
|  | [´ÜÀ§ : ¹è] | | ±¸ºÐ | 2008.12 | 2009.12 | 2010.12 | 2011.03 | | PER(ÃÖ°í/ÃÖÀú) | 87.14 /25.36 | 40.37 /17.41 | - /- | 331.25 /189.75 | | PSR(ÃÖ°í/ÃÖÀú) | 1.81 /0.53 | 1.50 /0.64 | 1.52 /0.88 | 2.32 /1.33 | | PBR(ÃÖ°í/ÃÖÀú) | 1.25 /0.36 | 1.11 /0.48 | 1.04 /0.61 | 1.40 /0.80 | | PCR(ÃÖ°í/ÃÖÀú) | 11.97 /3.48 | 11.04 /4.76 | 60.21 /34.94 | 59.06 /33.83 | |
|  | [´ç»ç/ÀǷᡤÁ¤¹Ð±â±â/KOSDAQ] | | ±¸ºÐ | 2009.12 | 2010.12 | | º£Å¸(¥â) | 1.25 /1.07 /1.00 | 1.06 /0.88 /1.00 | | º¯µ¿¼º(¥ò) | 67.20 /30.41 /24.11 | 42.67 /20.82 /17.40 | |
|  | [´ÜÀ§ : ¾ï¿ø, %] | | ±¸ºÐ | 2007.12 | 2008.12 | 2009.12 | 2010.12 | | ´ç »ç | ¾÷Á¾Æò±Õ | ´ç »ç | ¾÷Á¾Æò±Õ | ´ç »ç | ¾÷Á¾Æò±Õ | ´ç »ç | ¾÷Á¾Æò±Õ | | Æò±ÕÅõÀÚÀÚº»(IC) | 525 | 188 | 533 | 248 | 530 | 278 | 555 | 234 | | ¼¼ÈÄ¿µ¾÷ÀÌÀÍ(NOPLAT) | 4 | 14 | -15 | 30 | 31 | 25 | -1 | 19 | | ÅõÀÚÀÚº»¼öÀÍ·ü(ROIC) | 0.91 | 7.49 | -2.97 | 12.41 | 5.96 | 9.02 | -0.24 | 8.10 | | °¡Á߯ò±ÕÀÚº»ºñ¿ë(WACC) | 5.86 | 7.52 | 7.70 | 7.27 | 8.35 | 6.76 | 7.18 | 6.80 | | EVA | -26.0 | -0.0 | -57.0 | 12.7 | -12.6 | 6.2 | -41.2 | 3.0 | |
|  | [´ÜÀ§ : ¾ï¿ø, ¹è] | | ±¸ºÐ | 2008.12 | 2009.12 | 2010.12 | 2011.03 | | ±â¾÷°¡Ä¡ (EV) | 322.77 | 499.47 | 477.97 | 729.79 | | EBITDA | 42.05 | 52.22 | 25.78 | 33.35 | | EBITDA/¸ÅÃâ¾× | 0.14 | 0.16 | 0.09 | 0.12 | | EBITDA/±ÝÀ¶ºñ¿ë | 3.60 | 4.17 | 2.01 | 2.67 | | EV/EBITDA | 7.68 | 9.56 | 18.54 | 21.89 | |
|
| |
|